Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_assertion description "[Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_assertion evidence source_evidence_literature NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_assertion SIO_000772 12616956 NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_assertion wasDerivedFrom befree-2016 NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_assertion wasGeneratedBy ECO_0000203 NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.
- befree-2016 importedOn "2016-02-19" NP385626.RAKoU7Y4Gz7SK9Bt5Wpa2pRlAlF4do7VWE2NkVD1mbkYg130_provenance.